Is this the main reason why Guardion Health Sciences (GHSI) shares surged in the after-‎hours?

YEXT Stock

Guardion Health Sciences, (GHSI) serves as a specialist health sciences corporation in the ‎United States and its subsidiaries. The organization works in two divisions, medical food, and ‎medical devices. Medical Foods provides Lumega-Z, balanced nutrition that refills and ‎replaces the macular antioxidant pigment, and GlaucoCetin. This vision-specific medical ‎food promotes and preserves the optic nerve […]

Let’s take a look at how Venus Concept Inc. (VERO) plunged in the Pre-market

PLAG Stock

NASDAQ-listed Venus Concept Inc. (VERO), shares plunged 18.5% to $2.07 in the early hours today after a global medical aesthetic technology leader announced that it aims to make an underwritten public offering of Venus common stock under its existing shelf registration statement, subject to pertinent market and other conditions. Venus Concept will be selling all […]

TOP Losers Today in Pre Market

Pre-market data show Naked Brand Group Limited (NASDAQ:NAKD) is -2.44% lower at $0.1561. It recently closed at $0.16, fluctuating in a day’s range from $0.1426 to $0.169 and a 52-week trading range of $0.07 to $3.70. Zomedica Corp. (AMEX:ZOM) is trading at $0.1591 down with -2.15 percent or -0.0 point in pre-market trading today. It […]

No matter how Codexis (Nasdaq: CDXS) shares jumped in the late session on Friday

SFT Stock

A leading protein engineering firm, Codexis (Nasdaq: CDXS), stock in postmarket trade has grown 14.17% to $7.001. There does not seem to be any business news that today prompted the price of Codexis share to surge, and investors would want to take this as a signal for warning. However, on December 02, 2020, the pricing […]

Is that why Aerpio Pharmaceuticals (Nasdaq: ARPO) stock plunged in the AH session?

MTTR

Aerpio Pharmaceuticals, (Nasdaq: ARPO), the stock dipped -40.89% to $1.33 in the After-market session, as Razuprotafib met its primary efficacy endpoint at 28 days in Aerpio’s double-blind Phase 2 trial in patients with elevated intraocular pressure associated with open-angle glaucoma and ocular hypertension. Compared to the monotherapy group, razuprotafib did not show any statistically significant […]

Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) shares up in the sky after this update

Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) stock soared 17.36% to $1.42 in the pre-market trading session following an announcement by a biopharmaceutical corporation focusing on advancing immunology-based treatments for common inflammatory disorders that two collaboration have been reached to explore potential therapeutic applications for its immunomodulatory drug, Ampion. The Organization has entered into a cooperative […]